Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection
Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection
复制标题
ORF2分泌形式在戊型肝炎病毒感染中的起源、抗原性和功能
DOI:
10.1073/pnas.1721345115
复制
发表时间:
2018-05-01
影响因子:
11.1
通讯作者:
Feng, Zongdi
中科院分区:
文献类型:
--
作者:
Yin, Xin;Ying, Dong;Feng, Zongdi
Significance Hepatitis E virus (HEV) is a main cause of acute hepatitis worldwide. Recent evidence suggests that HEV-infected cells release a secreted form of ORF2 protein (ORF2S) but its origin and function are unknown. Here we demonstrate that ORF2S and ORF2C (the actual capsid protein) are different translation products and that ORF2S is not essential for the HEV life cycle but inhibits antibody-mediated neutralization of HEV. Our results have important implications for understanding the HEV replication cycle and immune evasion mechanisms. The identified internal start codon in this study is highly conserved in most HEV strains, suggesting that the production of ORF2S is an evolutionary conserved function for HEV. The enterically transmitted hepatitis E virus (HEV) adopts a unique strategy to exit cells by cloaking its capsid (encoded by the viral ORF2 gene) and circulating in the blood as “quasi-enveloped” particles. However, recent evidence suggests that the majority of the ORF2 protein present in the patient serum and supernatants of HEV-infected cell culture exists in a free form and is not associated with virus particles. The origin and biological functions of this secreted form of ORF2 (ORF2S) are unknown. Here we show that production of ORF2S results from translation initiated at the previously presumed AUG start codon for the capsid protein, whereas translation of the actual capsid protein (ORF2C) is initiated at a previously unrecognized internal AUG codon (15 codons downstream of the first AUG). The addition of 15 amino acids to the N terminus of the capsid protein creates a signal sequence that drives ORF2S secretion via the secretory pathway. Unlike ORF2C, ORF2S is glycosylated and exists as a dimer. Nonetheless, ORF2S exhibits substantial antigenic overlap with the capsid, but the epitopes predicted to bind the putative cell receptor are lost. Consistent with this, ORF2S does not block HEV cell entry but inhibits antibody-mediated neutralization. These results reveal a previously unrecognized aspect in HEV biology and shed new light on the immune evasion mechanisms and pathogenesis of this virus.